← Evidence map

ArticleLeukemia2012

EXEL-8232, a small-molecule JAK2 inhibitor, effectively treats thrombocytosis and extramedullary hematopoiesis in a murine model of myeloproliferative neoplasm induced by MPLW515L.

G Wernig et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2012

2013

2014

2015

2016

2017

2018

2019

2020

this papercites it

EXEL-8232, a small-molecule JAK2 inhibitor, effectively treats thrombocytosis and extramedullary hematopoiesis in a murine model of myeloproliferative neoplasm induced by MPLW515L. | OpenQuestion